MORE ON PATIENT RESOURCES
Eligible* patients who are commercially insured and covered may pay as little as $35 per fill
Patients can text “Zilxi” to 66580 or click below for savings card and complete terms, conditions, and eligibility requirements.
*Additional Eligibility Criteria & Terms:
This co-pay card is not valid for use by patients who are covered by any federal or state funded healthcare program (including, but not limited to, Medicare [Part D and Medigap], Medicaid, any state pharmaceutical assistance program, TRICARE, VA, or DoD). Offer good only in the U.S., including Puerto Rico. This card is good for use only with a valid Zilxi prescription at the time the prescription is filled by the pharmacist and dispensed to the patient. Void where prohibited by law, taxed, or restricted. This offer cannot be combined with any other promotional offer. For full terms and conditions, click here.
ZILXI PATIENT BROCHURE
DOWNLOAD BROCHUREContraindications
Persons who have shown hypersensitivity to any of the tetracyclines or any other ingredient in ZILXI.
Warnings and Precautions
Flammability: The propellant in ZILXI is flammable. Instruct the patient to avoid fire, flame, and smoking during and immediately following application.
ZILXI is a topical foam. While systemic absorption of ZILXI is low, and serious adverse reactions were not seen in clinical studies, the following adverse reactions associated with oral minocycline should be considered:
Adverse Reactions
The most common adverse reaction reported during clinical trials of ZILXI was diarrhea.
Indications and Usage
ZILXI (minocycline) topical foam, 1.5% is a tetracycline-class drug indicated for the treatment of inflammatory lesions of rosacea in adults.
Limitations of Use: This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, ZILXI should be used only as indicated.
Please click to access full Prescribing Information.
Contraindications
Persons who have shown hypersensitivity to any of the tetracyclines or any other ingredient in ZILXI.
Warnings and Precautions
Flammability: The propellant in ZILXI is flammable. Instruct the patient to avoid fire, flame, and smoking during and immediately following application.
ZILXI is a topical foam. While systemic absorption of ZILXI is low, and serious adverse reactions were not seen in clinical studies, the following adverse reactions associated with oral minocycline should be considered:
Adverse Reactions
The most common adverse reaction reported during clinical trials of ZILXI was diarrhea.
Indications and Usage
ZILXI (minocycline) topical foam, 1.5% is a tetracycline-class drug indicated for the treatment of inflammatory lesions of rosacea in adults.
Limitations of Use: This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, ZILXI should be used only as indicated.
Please click to access full Prescribing Information.
REFERENCES